Related Experiment Video
Updated: Sep 28, 2025

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Soft Tissue and Osseous Substitutes for the Diabetic Foot
Steven L Stuto1, Crystal L Ramanujam1, Thomas Zgonis1
1Division of Podiatric Medicine and Surgery, Department of Orthopaedics, University of Texas Health San Antonio, 7703 Floyd Curl Drive, MC 7776, San Antonio, TX 78229, USA.
Advanced orthobiologics offer solutions for diabetic foot and ankle reconstruction when traditional grafts are not feasible. This review discusses various substitutes and their specific clinical uses in complex cases.
Area of Science:
- Orthopedics
- Biomaterials Science
- Diabetic Foot Care
Background:
- Diabetic foot and ankle reconstruction presents unique challenges.
- Autogenous grafts are standard but often limited in diabetic patients.
- Availability of soft tissue and osseous substitutes has increased.
Purpose of the Study:
- To review advanced orthobiologics for diabetic foot and ankle reconstruction.
- To discuss clinical indications for various substitutes.
- To guide selection based on patient status and defect type.
Main Methods:
- Literature review of advanced orthobiologics.
- Analysis of clinical indications and patient factors.
- Synthesis of current evidence on substitute use.
Main Results:
- Several orthobiologic substitutes are available for diabetic foot reconstruction.
- Selection criteria include patient health, tissue loss, and functional demands.
- Specific advanced materials have defined roles in complex cases.
Conclusions:
- Orthobiologics provide viable alternatives in diabetic foot reconstruction.
- Careful patient and defect assessment is crucial for appropriate substitute selection.
- These advanced materials expand treatment options for challenging scenarios.
Related Concept Videos
Bones of the Lower Limb: Tibia and Fibula
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

